Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
- Viral Infection
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 364018
Zika Virus is a virus that is spread by mosquitoes.
IPSCIO Record ID: 381834
University further granted Licensee the right to grant sublicenses. All rights granted to Licensee were reserved to University.
Patent 62/431,550 'Differential Molecular Diagnostic Assay for Zika'
The research program is in the field of CII-ArboViroPlex rRT-PCR Test, a multiplex assay that can simultaneously test, detect and differentiate the Zika virus, all Dengue virus serotypes, Chikungunya virus and West Nile virus. The key advantage of this diagnostic kit is the ability to detect and differentiate almost instantaneously the four viruses.
IPSCIO Record ID: 248395
Licensed Product shall mean a Plague Antigen, and/or a Vaccine including but not limited to a Plague Vaccine Dose, the manufacture, use, sale, keeping, importing or exporting of which would, in the absence of the license granted under this Agreement, constitute an infringement of the Patents or that uses other Intellectual Property.
Plague Antigen shall mean individually each of the F1 antigen and V antigen of Yesinnia Pestis.
Plague Vaccine Dose shall mean the quantity of Vaccine given to an individual in a single dose.
Patents are for Plague Vaccines and Vaccine Compositions.
IPSCIO Record ID: 277105
This agreement contains both exclusive and non-exclusive grants between the parties.
Licensed Product shall mean a therapeutic or prophylactic vaccine the manufacture. use or sale of which, but for any license granted to Licensee herein, would infringe a Valid Claim of one or more Licensor Patent Rights or one or more Collaboration Patent Rights, or was developed or manufactured using Licensor Know-How.
PADREÂ® Technology shall mean a family of immunostimulatory molecules which when combined with cytotoxic T cell epitopes increase the magnitude and duration of the immune response.